Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

3.53USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$3.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
77,120
52-wk High
$29.02
52-wk Low
$3.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 19.38 -0.144
Mar '18 11.19 -0.402
FY 2017 Dec '17 12.99 -0.290
Sep '17 18.08 -0.127
Jun '17 20.29 -0.105
Mar '17 20.29 -0.017
FY 2016 Dec '16 20.29 0.076
Sep '16 16.91 0.004
Jun '16 0.00 -0.238
Mar '16 0.00 -6.811
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 12.63 15.00 9.90 62.83
Quarter Ending Mar-19 4 21.99 44.10 13.38 --
Year Ending Dec-18 6 57.70 60.00 55.00 117.64
Year Ending Dec-19 6 62.09 86.00 43.00 72.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.34 -0.25 -0.46 2.50
Quarter Ending Mar-19 4 -0.07 0.63 -0.33 --
Year Ending Dec-18 6 -1.13 -1.03 -1.24 -0.11
Year Ending Dec-19 6 -1.29 -0.25 -2.33 -2.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -- 0.66 0.95
Price to Sales (TTM) 2.36 242.95 21.76
Price to Book (MRQ) 1.32 18.87 4.53
Price to Tangible Book (MRQ) 1.32 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -19.63 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -26.42 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -84.37 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago -516.59 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 3.07 6.87 3.68
LT Debt to Equity (MRQ) 0.00 16.70 9.53
Total Debt to Equity (MRQ) 0.00 21.89 13.39
Interest Coverage (TTM) -- -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -61.82 -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -68.34 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -62.30 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -59.74 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 518,661 28,103,806 878,349,382
Net Income/Employee (TTM) -309,848 -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.21 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -12.59 0.35 11.06
Return on Assets - 5 Yr. Avg. -- 2.90 11.85
Return on Investment (TTM) -16.58 0.60 13.80
Return on Investment - 5 Yr. Avg. -- 2.87 15.17
Return on Equity (TTM) -24.92 -2.18 15.29
Return on Equity - 5 Yr. Avg. -- -0.88 16.29
  1 Year 3 Year 5 Year
Sales % 92.61 -- --
EPS (TTM) % 20.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Jounce Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.71 -0.69 99 99
13 Week -47.76 -43.56 25 94
26 Week -62.76 -62.65 22 96
52 Week -72.85 -73.66 21 98
YTD -67.14 -67.24 29 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.05%
# of Holders: 125
Total Shares Held: 26,502,497
3 Mo. Net Change: -521,869
# New Positions: 22
# Closed Positions: 19
# Increased Positions: 61
# Reduced Positions: 41
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.